Michael J Krowka1, Richard N Channick2, Hilary M DuBrock2, David S Goldberg3, Norman L Sussman4, Sonja D Bartolome5, Zakiyah Kadry6, Reena J Salgia7, David C Mulligan8, Walter K Kremers9, Steven M Kawut3. 1. Department of Medicine, Mayo Clinic Rochester, MN USA. 2. Department of Medicine, Massachusetts General Hospital Boston, MA USA. 3. Department of Medicine, Perelman School of Medicine at the University of Pennsylvania Philadelphia, PA USA. 4. Department of Surgery, Baylor College of Medicine Houston TX USA. 5. Department of Medicine, University of Texas Southwestern Medical Center Dallas, TX USA. 6. Department of Surgery, Division of Transplantation, Penn State Milton S. Hershey Medical Center Hershey, PA USA. 7. Department of Medicine, Henry Ford Hospital Detroit, MI USA. 8. Department of Surgery, Transplantation and Immunology, Yale University New Haven, CT USA. 9. Department of Health Sciences Research, Mayo Clinic Rochester, MN USA.
Abstract
BACKGROUND: The current Organ Procurement Transplantation Network policy grants Model for End-Stage Liver Disease (MELD) exception points to patients with portopulmonary hypertension (POPH), but potentially important factors, such as severity of liver disease and pulmonary hypertension, are not included in the exception score, and may affect survival. The purpose of this study was to identify significant predictors of waitlist mortality in patients with POPH. METHODS: We performed a retrospective cohort study of patients in the Organ Procurement and Transplantation Network database with hemodynamics consistent with POPH (defined as mean pulmonary arterial pressure >25 mm Hg and pulmonary vascular resistance [PVR] ≥240 dynes·s·cm) who were approved for a POPH MELD exception between 2006 and 2014. Using a Cox proportional hazards model, we identified predictors of waitlist mortality (or removal for clinical deterioration). RESULTS: One hundred ninety adults were included. Age (hazard ratio [HR], 1.04; 95% confidence interval [CI], 1.00-1.08; P = 0.0499), initial native MELD score (HR, 1.11; 95% CI, 1.05-1.17; P < 0.001), and initial PVR (HR, 1.12 per 100 dynes·s·cm; 95% CI, 1.02-1.23; P = 0.02) were the only significant univariate predictors of waitlist mortality and remained significant predictors in a multivariate model, which had a c-statistic of 0.71. PVR and mean pulmonary arterial pressure were not significant predictors of posttransplant mortality. CONCLUSIONS: Both the severity of liver disease and POPH (as assessed by MELD and PVR, respectively) were significantly associated with waitlist, but not posttransplant, mortality in patients with approved MELD exceptions for POPH. Both factors should potentially be included in the POPH MELD exception score to more accurately reflect waitlist mortality risk.
BACKGROUND: The current Organ Procurement Transplantation Network policy grants Model for End-Stage Liver Disease (MELD) exception points to patients with portopulmonary hypertension (POPH), but potentially important factors, such as severity of liver disease and pulmonary hypertension, are not included in the exception score, and may affect survival. The purpose of this study was to identify significant predictors of waitlist mortality in patients with POPH. METHODS: We performed a retrospective cohort study of patients in the Organ Procurement and Transplantation Network database with hemodynamics consistent with POPH (defined as mean pulmonary arterial pressure >25 mm Hg and pulmonary vascular resistance [PVR] ≥240 dynes·s·cm) who were approved for a POPH MELD exception between 2006 and 2014. Using a Cox proportional hazards model, we identified predictors of waitlist mortality (or removal for clinical deterioration). RESULTS: One hundred ninety adults were included. Age (hazard ratio [HR], 1.04; 95% confidence interval [CI], 1.00-1.08; P = 0.0499), initial native MELD score (HR, 1.11; 95% CI, 1.05-1.17; P < 0.001), and initial PVR (HR, 1.12 per 100 dynes·s·cm; 95% CI, 1.02-1.23; P = 0.02) were the only significant univariate predictors of waitlist mortality and remained significant predictors in a multivariate model, which had a c-statistic of 0.71. PVR and mean pulmonary arterial pressure were not significant predictors of posttransplant mortality. CONCLUSIONS: Both the severity of liver disease and POPH (as assessed by MELD and PVR, respectively) were significantly associated with waitlist, but not posttransplant, mortality in patients with approved MELD exceptions for POPH. Both factors should potentially be included in the POPH MELD exception score to more accurately reflect waitlist mortality risk.
Authors: R H Wiesner; S V McDiarmid; P S Kamath; E B Edwards; M Malinchoc; W K Kremers; R A Krom; W R Kim Journal: Liver Transpl Date: 2001-07 Impact factor: 5.799
Authors: N Sussman; V Kaza; N Barshes; R Stribling; J Goss; C O'Mahony; E Zhang; J Vierling; A Frost Journal: Am J Transplant Date: 2006-06-22 Impact factor: 8.086
Authors: Marius M Hoeper; Harm Jan Bogaard; Robin Condliffe; Robert Frantz; Dinesh Khanna; Marcin Kurzyna; David Langleben; Alessandra Manes; Toru Satoh; Fernando Torres; Martin R Wilkins; David B Badesch Journal: J Am Coll Cardiol Date: 2013-12-24 Impact factor: 24.094
Authors: M Torregrosa; J Genesca; A Gonzalez; A Evangelista; A Mora; C Margarit; R Esteban; J Guardia Journal: Transplantation Date: 2001-02-27 Impact factor: 4.939
Authors: Michael J Krowka; Dave P Miller; Robyn J Barst; Darren Taichman; Raed A Dweik; David B Badesch; Michael D McGoon Journal: Chest Date: 2011-07-21 Impact factor: 9.410
Authors: Arun Jose; Shimul A Shah; Nadeem Anwar; Courtney R Jones; Kenneth E Sherman; Jean M Elwing Journal: Liver Transpl Date: 2021-06-29 Impact factor: 6.112
Authors: Michelle C Sykes; Christina Ireland; Julia E McSweeney; Emily Rosenholm; Kristofer G Andren; Thomas J Kulik Journal: Pulm Circ Date: 2018-04-30 Impact factor: 3.017
Authors: Hilary M DuBrock; Reena J Salgia; Norman L Sussman; Sonja D Bartolome; Zakiyah Kadry; David C Mulligan; Sarah Jenkins; Kandace Lackore; Richard N Channick; Steven M Kawut; Michael J Krowka Journal: Transplant Direct Date: 2019-05-22
Authors: Sandeep Sahay; Sami Al Abdi; Celia Melillo; Jennie Newman; Raed A Dweik; Gustavo A Heresi; Adriano R Tonelli Journal: Transplant Direct Date: 2021-06-08
Authors: Michael Krowka; Emmanuelle Cottreel; Marius M Hoeper; Nick H Kim; Nicolas Martin; Olivier Sitbon; Jaume Bosch Journal: Liver Transpl Date: 2020-04-30 Impact factor: 5.799
Authors: Hilary M DuBrock; Rodrigo Cartin-Ceba; Richard N Channick; Steven M Kawut; Michael J Krowka Journal: Chest Date: 2020-08-13 Impact factor: 9.410